Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-02-26

FDA Approved: TOPIRAMATE — Supplemental Application (Ascend Laboratories, LLC)

View source ↗

Summary

FDA approved a supplemental application for Topiramate by Ascend Laboratories, LLC (ANDA 217795), resulting in an updated regulatory action for this generic pro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topiramate (Topiramate)

Snippet

SUPPL AP for TOPIRAMATE (TOPIRAMATE)